S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › RGSS › Research report
← RGSS page
XStocksXray
Market X-Ray report · 19 October 2026

Rosgosstrakh OAO (RGSS)

Moscow Exchange · Russia · prices in RUB · close of 19 Oct 2026

Key indicators

Last closeRUB 0.178
52-week range0.135 – 0.250
Return, 1 month / 3 months−0.7% / +11.9%
Return, 1 year / 3 years−12.1% / −40.9%
TrendBelow its 200-day average
RSI (14)44
Volatility (1 year)39.0%
Worst drawdown (1 year)-38.4%
Average daily value traded3.64M RUB
Dividend yield–

Market X-Ray price-based

56/ 100 · High confidence · ahead of 59% of stocks on this exchange
Trend64
Momentum57
Stability (higher is calmer)57
Liquidity38
Income–

Five-year price chart navy: price · brown: 200-day average

0.100.180.250.330.412021-112023-022024-042025-072026-10

About the company

Rosgosstrakh is a Russian insurance company based in Moscow. It provides insurance cover to individuals and to businesses, offering policies for motor, property, personal accident and health, and life, along with related services through its branch network across the country. Its customers include private households and corporate clients who buy protection against everyday risks and larger commercial exposures.

On this site Rosgosstrakh OAO appears as a stock on the Moscow Exchange (Russia), code RGSS, with prices in Russian rubles (RUB). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Rosgosstrakh OAO (RGSS) trades on the Moscow Exchange in Russia. It last closed at RUB 0.178 on 19 October 2026.

Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 103 of 250 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 12.1% and over the last three months it rose 11.9%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Rosgosstrakh OAO (RGSS)

The five lenses in numbers each metric is ranked against the other stocks on Moscow Exchange

Lens and metricValueScoreReading
Trend64 · FairMixed trend against its averages.
Above 200-day average-7.9%
From 52-week high-21.9%
Momentum57 · FairTypical recent returns for this exchange.
3-month return12.0%
6-month return-11.3%
12-month return, skipping the last month-11.6%
Stability (higher is calmer)57 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)39.0%
Worst drawdown, 1 year (smaller is calmer)-38.4%
Liquidity38 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded3.64M RUB
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−1.7%
1 month−0.7%
3 months+11.9%
6 months−11.3%
1 year−12.1%
3 years−40.9%
5 years−24.2%

Signals

50-day / 200-day average0.184 / 0.193
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.007

Technical summary

DailyStrongly bearish0 bullish · 4 neutral · 12 bearish
WeeklyStrongly bearish1 bullish · 1 neutral · 10 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

Recent dividends

Ex-dividend dateAmount per share
11 Jan 2021RUB 0.0250

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Moscow Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026